- Chart
- Upturn Summary
- Highlights
- Valuation
- About
Sharps Technology Inc. Warrant (STSSW)

- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/23/2025: STSSW (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type Stock | Historic Profit -76.56% | Avg. Invested days 27 | Today’s Advisory PASS |
Upturn Star Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Key Highlights
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 1.92 | 52 Weeks Range 0.01 - 0.14 | Updated Date 05/24/2025 |
52 Weeks Range 0.01 - 0.14 | Updated Date 05/24/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.96 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) - |
Management Effectiveness
Return on Assets (TTM) -42.67% | Return on Equity (TTM) -75.14% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value - | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating 1017855 |
Shares Outstanding - | Shares Floating 1017855 | ||
Percent Insiders - | Percent Institutions - |
Upturn AI SWOT
Sharps Technology Inc. Warrant
Company Overview
History and Background
Sharps Technology Inc. Warrant (often referred to in the context of the underlying company, Sharps Technology, Inc.) is a special type of security that gives the holder the right, but not the obligation, to purchase shares of Sharps Technology, Inc. at a predetermined price within a specific timeframe. Sharps Technology, Inc. focuses on developing and commercializing innovative medical sharps disposal solutions. The company aims to address the critical issue of needlestick injuries and the safe disposal of medical waste. Significant milestones for the company would likely involve product development, regulatory approvals, and strategic partnerships related to their disposal technology. The evolution of the warrant is tied to the performance and corporate actions of Sharps Technology, Inc.
Core Business Areas
- Medical Sharps Disposal Technology: Sharps Technology Inc. is focused on developing and marketing a proprietary, integrated system for the safe and efficient disposal of used medical sharps. This system aims to prevent accidental needlestick injuries and reduce the environmental impact of medical waste. Key components of their offering typically include innovative sharps containers and disposal mechanisms.
Leadership and Structure
Information regarding the specific leadership and organizational structure of Sharps Technology Inc. Warrant is intrinsically linked to the parent company, Sharps Technology, Inc. The warrant is a financial instrument and does not have its own operational leadership. However, the leadership of Sharps Technology, Inc., including its Board of Directors and executive management team, indirectly influences the value and performance of the warrants.
Top Products and Market Share
Key Offerings
- Sharps Disposal System: Sharps Technology's primary offering is a unique, integrated system designed for the safe and effective disposal of used medical sharps. This system is intended to significantly reduce the risk of needlestick injuries, which are a major concern in healthcare settings. The system aims to be more user-friendly and secure than traditional methods. Specific market share data for this niche product is not readily available, as it is a specialized technology in a market with established players. Competitors include manufacturers of traditional sharps containers and other advanced disposal systems.
Market Dynamics
Industry Overview
Sharps Technology Inc. operates within the broader medical waste management and infection control industry. This sector is driven by stringent regulations, growing awareness of healthcare-associated infections, and the increasing volume of medical procedures. The demand for safe and efficient sharps disposal solutions is consistently high due to the inherent risks associated with needlestick injuries.
Positioning
Sharps Technology Inc. aims to position itself as an innovator in sharps disposal with a focus on safety and efficiency. Their competitive advantage lies in their proprietary technology, which they claim offers superior protection and user experience compared to conventional methods. However, they face competition from established manufacturers of medical waste disposal products.
Total Addressable Market (TAM)
The total addressable market for medical sharps disposal is substantial, encompassing hospitals, clinics, laboratories, and other healthcare facilities globally. While precise TAM figures for this segment can vary, it is a multi-billion dollar market driven by the continuous generation of sharps waste. Sharps Technology Inc. is positioned to capture a portion of this market by offering a differentiated and potentially superior solution.
Upturn SWOT Analysis
Strengths
- Proprietary innovative technology for sharps disposal.
- Focus on addressing critical safety concerns (needlestick injuries).
- Potential for regulatory compliance advantages.
- Growing global awareness of healthcare-associated infections.
Weaknesses
- As a relatively new entrant, brand recognition may be lower than established competitors.
- Dependence on the successful commercialization and adoption of its technology.
- Potential challenges in scaling manufacturing and distribution.
- Financial resources may be limited compared to larger, established players.
Opportunities
- Increasing regulatory emphasis on healthcare safety and waste management.
- Partnerships with large healthcare systems and distributors.
- Expansion into international markets with growing healthcare sectors.
- Development of next-generation disposal technologies.
Threats
- Competition from established manufacturers of sharps containers.
- Price sensitivity in the healthcare sector.
- Potential for technological obsolescence if competitors innovate faster.
- Changes in healthcare regulations or reimbursement policies.
Competitors and Market Share
Key Competitors
- Becton Dickinson and Company (BDX)
- Cardinal Health, Inc. (CAH)
Competitive Landscape
Sharps Technology Inc. faces intense competition from well-established players with significant market share, brand recognition, and extensive distribution networks. While their innovative technology offers a potential competitive edge, overcoming the inertia and established relationships of larger competitors will be a key challenge.
Growth Trajectory and Initiatives
Historical Growth: Historical growth for Sharps Technology Inc. Warrant is contingent on the growth and market acceptance of the underlying company's products and services. This would involve tracking the development and commercialization of their sharps disposal technology.
Future Projections: Future projections for the warrant depend on the projected success of Sharps Technology, Inc. in gaining market share, achieving profitability, and expanding its product offerings. Analyst estimates for the underlying company would be the primary source of future growth projections.
Recent Initiatives: Recent initiatives would likely involve efforts by Sharps Technology, Inc. to secure distribution agreements, gain regulatory approvals in new markets, and enhance its product portfolio to further penetrate the medical waste disposal market.
Summary
Sharps Technology Inc. Warrant is a derivative security whose value is tied to the success of its underlying company, Sharps Technology, Inc. The company's focus on innovative medical sharps disposal technology addresses a critical safety need. While their proprietary solution offers a potential advantage, they face significant competition from established players in a regulated market. Success hinges on market adoption, regulatory approvals, and effective scaling of their operations.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company filings (SEC)
- Industry reports on medical waste management
- Financial news and analysis platforms
Disclaimers:
This information is provided for informational purposes only and does not constitute investment advice. The value of warrants is highly speculative and can be lost entirely. Investors should conduct their own due diligence and consult with a qualified financial advisor before making any investment decisions. Market share data for niche products can be estimated and may vary.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Sharps Technology Inc. Warrant
Exchange NASDAQ | Headquaters Melville, NY, United States | ||
IPO Launch date 2022-04-14 | CEO & Director Mr. Robert M. Hayes | ||
Sector Healthcare | Industry Medical Instruments & Supplies | Full time employees 55 | Website https://sharpstechnology.com |
Full time employees 55 | Website https://sharpstechnology.com | ||
Sharps Technology, Inc., a medical device and pharmaceutical packaging company, engages in the design, research and development, manufacturing, and commercialization of safety syringe products in the United States. The company provides safety syringe products comprising Securgard, Sologard, and Sharps Provensa that are ultra-low waste syringes for passive, and safety and reuse prevention features, as well as develops prefillable syringe systems. The company was incorporated in 2017 and is based in Melville, New York.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
Home 

